文献速递消化道肿瘤与早癌

北欧双胞胎癌症研究中结直肠癌的家族风险与遗传度

Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-01-24

该研究分析北欧双胞胎癌症研究中39,990名同卵与61,443名同性别异卵双胞胎,1943年至2010年期间1861人诊断结肠癌、1268人诊断直肠癌。同卵双胞胎中结直肠癌家族风险比(FRR)为3.1(95%CI 2.4-3.8),异卵为2.2(95%CI 1.7-2.7);结直肠癌风险变异的40%(95%CI 33%-48%)可归因于遗传因素。结论认为遗传差异可解释40%的结直肠癌易感性变异,结肠癌与直肠癌的遗传度可能低于结直肠癌整体。

要点

  • 同卵双胞胎结直肠癌FRR为3.1(95%CI 2.4-3.8),异卵双胞胎为2.2(95%CI 1.7-2.7)。
  • 结直肠癌风险变异的40%(95%CI 33%-48%)可归因于遗传因素。
  • 结肠癌与直肠癌的遗传度分别为16%(95%CI 0-46%)和15%(95%CI 0-50%)。

核心结论

  • 个体间遗传差异可解释40%(95%CI 33%-48%)的结直肠癌易感性变异。
  • 结肠癌与直肠癌的风险中遗传成分可能低于结直肠癌整体。
  • 结肠癌或直肠癌患者的同胞、尤其是同卵双胞胎应个性化考虑筛查。

研究设计与样本

  • 数据来自北欧双胞胎癌症研究,纳入39,990名同卵双胞胎和61,443名同性别异卵双胞胎。
  • 比较受累双胞胎的同胞患癌风险相对于队列风险的家族风险比(FRR)。
  • 估计风险变异中可归因于遗传因素的比例(遗传度)。

主要发现

  • 1943年最早登记至2010年,共1861人诊断结肠癌、1268人诊断直肠癌。
  • 同卵双胞胎结直肠癌FRR为3.1(95%CI 2.4-3.8),异卵双胞胎FRR为2.2(95%CI 1.7-2.7)。
  • 结肠癌FRR同卵为3.3(95%CI 2.1-4.5)、异卵为2.6(95%CI 1.7-3.5);直肠癌FRR同卵为3.3(95%CI 1.5-5.1)、异卵为2.6(95%CI 1.2-4.0)。
  • 结肠癌遗传度16%(95%CI 0-46%)、共同环境15%(95%CI 0-38%)、独特环境68%(95%CI 57%-79%)。
  • 直肠癌遗传度15%(95%CI 0-50%)、共同环境11%(95%CI 0-38%)、独特环境75%(95%CI 61%-88%)。

关键数值与推荐

  • 结直肠癌FRR:同卵双胞胎3.1(95%CI 2.4-3.8),异卵双胞胎2.2(95%CI 1.7-2.7)。
  • 结直肠癌遗传度40%(95%CI 33%-48%)。
  • 结肠癌遗传度16%(95%CI 0-46%),直肠癌遗传度15%(95%CI 0-50%)。

临床怎么用

  • 结肠癌或直肠癌患者的同胞、尤其是同卵双胞胎应个性化考虑筛查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We analyzed data from twins to determine how much the familial risk of colorectal cancer can be attributed to genetic factors vs environment. We also examined whether heritability is distinct for colon vs rectal cancer, given evidence of distinct etiologies. METHODS: Our data set included 39,990 monozygotic and 61,443 same-sex dizygotic twins from the Nordic Twin Study of Cancer. We compared each cancer's risk in twins of affected co-twins relative to the cohort risk (familial risk ratio [FRR]). We then estimated the proportion of variation in risk that could be attributed to genetic factors (heritability). RESULTS: From earliest registration in 1943 through 2010, there were 1861 individuals diagnosed with colon cancer and 1268 diagnosed with rectal cancer. Monozygotic twins of affected co-twins had an FRR for colorectal cancer of 3.1 (95% confidence interval [CI], 2.4-3.8) relative to the cohort risk. Dizygotic twins of affected co-twins had an FRR for colorectal cancer of 2.2 (95% CI, 1.7-2.7). We estimated that 40% (95% CI, 33%-48%) of the variation in colorectal cancer risk could be attributed to genetic factors; unique environment only accounted for the remaining liability. For colon cancer, the FRR was 3.3 (95% CI, 2.1-4.5) for monozygotic twins and 2.6 (95% CI, 1.7-3.5) for dizygotic twins. For rectal cancer, comparable estimates were 3.3 (95% CI, 1.5-5.1) for monozygotic twins and 2.6 (95% CI, 1.2-4.0) for dizygotic twins. Heritability estimates for colon and rectal cancer were 16% (95% CI, 0-46%) and 15% (95% CI, 0-50%), common environment estimates were 15% (95% CI, 0-38%) and 11% (95% CI, 0-38%), and unique environment estimates were 68% (95% CI, 57%-79%) and 75% (95% CI, 61%-88%), respectively. CONCLUSIONS: Interindividual genetic differences could account for 40% of the variation in susceptibility to colorectal cancer; risk for colon and rectal cancers might have less of a genetic component than risk for colorectal cancer. Siblings, and particularly monozygotic co-twins, of individuals with colon or rectal cancer should consider personalized screening.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Graff RE, Möller S, Passarelli MN, et al. Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer. Clin Gastroenterol Hepatol. 2017. PMID: 28130150. doi:10.1016/j.cgh.2016.12.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。